UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005558
Receipt number R000006575
Scientific Title Effects on gas exchange of the extracorporeal membrane oxygenation in severe respiratory failure
Date of disclosure of the study information 2011/05/06
Last modified on 2020/05/12 09:49:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects on gas exchange of the extracorporeal membrane oxygenation in severe respiratory failure

Acronym

Effects on gas exchange of the extracorporeal membrane oxygenation in severe respiratory failure

Scientific Title

Effects on gas exchange of the extracorporeal membrane oxygenation in severe respiratory failure

Scientific Title:Acronym

Effects on gas exchange of the extracorporeal membrane oxygenation in severe respiratory failure

Region

Japan


Condition

Condition

severe respiratory failure

Classification by specialty

Pneumology Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of combined therapy with traditional ventilatory support using low tidal volume and extracorporeal membrane oxygenation (ECMO) in patients with severe respiratory failure, for minimizing the use of anticoagulants and mechanical damage on blood cells, and for avoiding the ventilator-induced lung injury

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in partial pressure of carbon dioxide and partial pressure of oxygen

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

ECMO-treated group. The combination therapy of ECMO and the conventional low tidal volume ventilation is introduced. Two venous cannulae are inserted in the jugular vein (for blood removal) and the femoral vein (for blood return) under the echo ultrasound-guidance. ACT is maintained around 150 seconds by heparin or nafamostat mesilate. The blood flow is controlled within 5-20 mL/min/kg (maximum 1000 mL/min), and the oxygen flow is adjusted within 3-5 L/min. When the discontinuation criteria are met, the treatment with ECMO is aborted. In this group, the concurrent ventilatory mode is limited to the conventional low tidal volume ventilation of less than 6 mL/kg.

Interventions/Control_2

Non-ECMO-treated group. The conventional low tidal volume ventilation alone is started. The ventilatory strategy is consisted of low tidal volume ventilation and open lung strategy recommended by ARDS Network.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)Patients with severe acute respiratory failure under mechanical ventilation (hypoxia of PaO2/FIO2 ratio <200mmHg, or hypercapnia of PaCO2 >=60mmHg)
(2)Documented informed consent can be obtained from the patient or his/her family for his/her participation in the study

Key exclusion criteria

(1)Patients with life-threatening respiratory failure
(2)Patients with contraindications to anticoagulant drugs
(3)Pregnant woman
(4)Patients who are considered inappropriate for enrollement in this study

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Nobuaki
Middle name
Last name Shime

Organization

Hiroshima University

Division name

Department of Emergency and Critical Care Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan

TEL

082-257-5456

Email

nshime@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Shinichiro
Middle name
Last name Ohshimo

Organization

Hiroshima University

Division name

Department of Emergency and Critical Care Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan

TEL

082-257-5456

Homepage URL


Email

ohshimos@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Policy Office, Hiroshima University

Address

1-2-3, Kasumi, Minami-kku, Hiroshima, 734-8551

Tel

082-257-5907

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2011 Year 05 Month 06 Day

Date of IRB

2011 Year 03 Month 09 Day

Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date

2031 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 05 Month 06 Day

Last modified on

2020 Year 05 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006575


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name